tiprankstipranks
Advertisement
Advertisement

PEPG Stock Latest News

Video: Deals in food and pharmaceuticals headline busy morning of M&A
The FlyVideo: Deals in food and pharmaceuticals headline busy morning of M&A
14d ago
UL
LLY
PepGen: Modest FREEDOM2 Efficacy, Regulatory Overhang, and Competitive Pressures Underscore Sell Rating
PremiumRatings
PepGen: Modest FREEDOM2 Efficacy, Regulatory Overhang, and Competitive Pressures Underscore Sell Rating
15d ago
PEPG
Buy Rating on PepGen: DM1 Program De-Risked by Stronger Underlying Biology and Upside from Higher-Dose Cohorts
PremiumRatings
Buy Rating on PepGen: DM1 Program De-Risked by Stronger Underlying Biology and Upside from Higher-Dose Cohorts
15d ago
PEPG
PepGen Reports Early Phase 2 FREEDOM2-DM1 Topline Data
PremiumCompany Announcements
PepGen Reports Early Phase 2 FREEDOM2-DM1 Topline Data
15d ago
8K
PEPG
Closing Bell Movers: Phreesia down over 20% after guidance cut
PremiumThe Fly
Closing Bell Movers: Phreesia down over 20% after guidance cut
15d ago
CVV
PHR
PepGen down 46% at $2.30 after Phase 2 Freedom trial data
PremiumThe FlyPepGen down 46% at $2.30 after Phase 2 Freedom trial data
15d ago
PEPG
PepGen Inc trading resumes
Premium
The Fly
PepGen Inc trading resumes
15d ago
PEPG
PepGen reports ‘promising’ topline results from MAD cohort
Premium
The Fly
PepGen reports ‘promising’ topline results from MAD cohort
15d ago
PEPG
PepGen Inc trading halted, news pending
PremiumThe Fly
PepGen Inc trading halted, news pending
15d ago
PEPG
Midday Fly By: Stocks tumble as oil prices climb again
PremiumThe Fly
Midday Fly By: Stocks tumble as oil prices climb again
1M ago
BJ
GO
PepGen: Clinical and Safety Uncertainties, FDA Partial Hold, and Valuation Gap Support Underperform Rating
PremiumRatings
PepGen: Clinical and Safety Uncertainties, FDA Partial Hold, and Valuation Gap Support Underperform Rating
1M ago
PEPG
Closing Bell Movers: Veeva up 13%, Broadcom up 5% on earnings beat
PremiumThe Fly
Closing Bell Movers: Veeva up 13%, Broadcom up 5% on earnings beat
1M ago
GO
AEO
PepGen Updates EDO Platform and DM1 Program Outlook
PremiumCompany AnnouncementsPepGen Updates EDO Platform and DM1 Program Outlook
1M ago
8K
PEPG
PepGen Inc trading resumes
Premium
The Fly
PepGen Inc trading resumes
1M ago
PEPG
PepGen Faces FDA Partial Hold Amid Ongoing FREEDOM2 Trial
Premium
Company Announcements
PepGen Faces FDA Partial Hold Amid Ongoing FREEDOM2 Trial
1M ago
8K
PEPG
PepGen announce FDA placed partial clinical hold on Phase 2 trial of PGN-EDODM1
PremiumThe Fly
PepGen announce FDA placed partial clinical hold on Phase 2 trial of PGN-EDODM1
1M ago
PEPG
PepGen reports Q4 EPS (27c), consensus (39c)
PremiumThe Fly
PepGen reports Q4 EPS (27c), consensus (39c)
1M ago
PEPG
PepGen Inc trading halted, news pending
PremiumThe Fly
PepGen Inc trading halted, news pending
1M ago
PEPG
Oppenheimer bullish on PepGen, initiates with an Outperform
PremiumThe Fly
Oppenheimer bullish on PepGen, initiates with an Outperform
2M ago
PEPG
PepGen price target raised to $7 from $6 at Guggenheim
PremiumThe FlyPepGen price target raised to $7 from $6 at Guggenheim
2M ago
PEPG
PepGen’s FREEDOM-DM1 Trial Reaches Early Safety Milestone for Myotonic Dystrophy
Premium
Company Announcements
PepGen’s FREEDOM-DM1 Trial Reaches Early Safety Milestone for Myotonic Dystrophy
2M ago
PEPG
PepGen Buy Rating: De-Risked Safety and Potential Category-Leading Efficacy for PGN-EDODM1 in DM1 Ahead of 1Q26 MAD Readout
Premium
Ratings
PepGen Buy Rating: De-Risked Safety and Potential Category-Leading Efficacy for PGN-EDODM1 in DM1 Ahead of 1Q26 MAD Readout
4M ago
PEPG

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >